Targeting insulin-like growth factor-1 to treat Alzheimer's disease

I Torres-Aleman - Expert opinion on therapeutic targets, 2007 - Taylor & Francis
The 'amyloid cascade hypothesis' proposes that disturbances in amyloid metabolism cause
Alzheimer's disease (AD). However, a comprehensive explanation of the mechanisms …

Potential roles of insulin and IGF-1 in Alzheimer's disease

L Gasparini, H Xu - Trends in neurosciences, 2003 - cell.com
Aging is characterized by a significant decline of metabolic and hormonal functions, which
often facilitates the onset of severe age-associated pathologies. One outstanding example of …

Insulin‐like growth factor‐2 is a promising candidate for the treatment and prevention of Alzheimer's disease

GS Fitzgerald, TG Chuchta… - CNS Neuroscience & …, 2023 - Wiley Online Library
Alzheimer's disease (AD) is the most common form of dementia. Current AD treatments slow
the rate of cognitive decline, but do not restore lost function. One reason for the low efficacy …

The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications

J Zemva, M Schubert - … (Formerly Current Drug Targets-CNS & …, 2014 - ingentaconnect.com
Recent data suggest that brains of patients with Alzheimer's disease (AD) are insulin and
insulin-like growth factor-1 (IGF-1) resistant. So far, there have been two different …

[HTML][HTML] The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease

B Kim, SE Elzinga, RE Henn, LM McGinley… - Neurobiology of …, 2019 - Elsevier
Alzheimer's disease (AD) is a growing problem worldwide, and there are currently no
effective treatments for this devastating disease. The neurotrophic growth factors insulin and …

The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease

S Freude, K Schilbach… - Current Alzheimer …, 2009 - ingentaconnect.com
In different clinical studies, an association of type 2 diabetes and Alzheimer's disease (AD)
has been described. However, the underlying mechanisms are still unclear. One …

Insulin-like growth factor I and Alzheimer´ s disease: therapeutic prospects?

E Carro, I Torres-Aleman - Expert review of neurotherapeutics, 2004 - Taylor & Francis
The search for a cure of Alzheimer´ s dementia is restless. In recent years, unexpected
epidemiological data showing a protective effect of anti-inflammatory and cholesterol …

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

E Carro, I Torres-Aleman - European journal of pharmacology, 2004 - Elsevier
Cellular and molecular processes leading to abnormal accumulation of β amyloid in the
brain are slowly being uncovered. A potential involvement of insulin and insulin-like growth …

The Role of Insulin-like Growth Factor I in Mechanisms of Resilience and Vulnerability to Sporadic Alzheimer's Disease

JA Zegarra-Valdivia, J Pignatelli, A Nuñez… - International Journal of …, 2023 - mdpi.com
Despite decades of intense research, disease-modifying therapeutic approaches for
Alzheimer's disease (AD) are still very much needed. Apart from the extensively analyzed …

Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease

SM de la Monte - Drugs, 2012 - Springer
Alzheimer's disease (AD) is the most common cause of dementia in North America. Growing
evidence supports the concept that AD is fundamentally a metabolic disease that results in …